The collective findings clearly illustrate that phosphorylation, elicited by either EGFR mutations or engagement with its ligand EGF, facilitates the enhanced secretion level of sEV PD-L1 in NSCLC cell lines. This evidence concerns the gene EGF and non-small cell lung carcinoma.